Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing lopinavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir + ritonavir 133.3mg/33.3mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lopinavir + ritonavir 80mg/20mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lopinavir and ritonavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lopinavir and ritonavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
Has precise active ingredient |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution |
Has precise active ingredient |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lopinavir and ritonavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir and ritonavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only lopinavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) |
Has precise active ingredient |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
Has precise active ingredient |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 40 mg and ritonavir 10 mg oral capsule |
Has precise active ingredient |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lopinavir 40 mg and ritonavir 10 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Lopinavir |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |